|
|
|||||||
![]() |
|||||||
|
|
|||||||
BILLING QUESTIONS |
|||||||
Medical billing is a complex system even for those who deal with it every day. There are many different insurance carriers, each with its own contract and terms of coverage. At CellNetix, it is our policy to work with our customers to reach swift and compassionate resolution of financial questions. How to beginPatients are requested to contact our billing office at 1-800-374-4045, Monday–Friday, 6:00am to 5:00pm, or email billing@cellnetix.com to initiate a conversation to resolve financial issues. Following are answers to our most frequently asked billing questions.
Q: Who are you? Q: What is this bill for? Q: Which doctor sent this invoice? Q: What is an “EOB”? Q: Why didn’t you bill my insurance?
Q: My Pap smear was reported as “Negative” yet it was reviewed by a pathologist. Why was it reviewed by a pathologist and why was I, as the patient, not informed of additional evaluation and additional charges? A: Many Pap slides are interpreted in the initial screening to contain reactive or reparative changes, atypical cells of undetermined significance, or to be in premalignant or malignant categories. CLIA ’88 Regulations (as published in the Federal Register, Vol. 57, No. 40, February 28, 1992, Section 493.1257, Paragraph c:1) mandate that these conditions be evaluated by a pathologist. The initial screening of a Pap smear is considered part of the Technical Component. A Pathologist’s Review of a Pap smear is not considered additional testing but is, rather, a continuation of the original Pap evaluation as requested by the healthcare provider and does not require notification to the patient. Sometimes the initially suspected condition results in a “Negative” report as determined by the pathologist. There is an additional charge for the Pathologist’s Review because it is considered a professional consultation and as such is an independent and different procedure code (CPT code) from the technical component. The Pathologist’s Review of a Pap smear is considered a Professional Fee. The Professional Fee may be billed separately from the original screen by a cytotechnologist. Advance notice to a patient of a required Pathologist’s Review is impossible because conditions requiring review are not determined until the initial screening of a Pap smear. |
|||||||